Premium
In Vivo Effects of Adenosine A 1 Receptor Agonist and Antagonist on Neuronal and Astrocytic Intermediary Metabolism Studied with Ex Vivo 13 C NMR Spectroscopy
Author(s) -
Håberg Asta,
Qu Hong,
Haraldseth Olav,
Unsgård Geirmund,
Sonnewald Ursula
Publication year - 2000
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1046/j.1471-4159.2000.0740327.x
Subject(s) - ccpa , adenosine , agonist , adenosine a1 receptor , glutamate receptor , glutamine , metabolism , medicine , endocrinology , biology , adenosine receptor , chemistry , biochemistry , receptor , amino acid
Adenosine is a neuromodulator, and it has been suggested that cerebral acetate metabolism induces adenosine formation. In the present study the effects that acetate has on cerebral intermediary metabolism, compared with those of glucose, were studied using the adenosine A 1 receptor agonist 2‐chloro‐ N 6 ‐cyclopentyladenosine (CCPA) and antagonist 8‐cyclopentyl‐1,3‐dipropylxanthine (DPCPX). Fasted rats received an intravenous injection of CCPA, DPCPX, or vehicle. Fifteen minutes later either [1,2‐ 13 C]acetate or [1‐ 13 C]glucose was given intraperitoneally; after another 30 min the rats were decapitated. Cortical extracts were analyzed with 13 C NMR spectroscopy and HPLC analysis. DPCPX affected neuronal and astrocytic metabolism. De novo synthesis of GABA from neuronal and astrocytic precursors was significantly reduced. De novo syntheses of glutamate and aspartate were at control levels, but their degradation was significantly elevated. In glutamine the anaplerotic activity and the amount of label in the position representing the second turn in the tricarboxylic acid cycle were significantly increased, suggesting elevated metabolic activity in astrocytes. CCPA did not influence GABA, aspartate, or glutamine synthesis. In glutamate the contribution from the astrocytic anaplerotic pathway was significantly decreased. In the present study the findings in the [1,2‐ 13 C]acetate and [1‐ 13 C]glucose control, CCPA, and DPCPX groups were complementary, and no adenosine A 1 agonist effects arising from cerebral acetate metabolism were detected.